FDA orders recall of intravenous pumps

The Food and Drug Administration announced the recall of 206,000 infusion pumps after three people died and six became seriously ill when the pumps shut down unexpectedly. The Baxter International Colleague volumetric infusion pumps stopped working for a variety of software, wiring and design reasons. Because some hospitals use only this brand of infusion pumps, the agency is asking users to employ other machines in critical cases and to monitor the machines closely.  The agency termed the recall Class 1, its most serious classification.

- read this report from The New York Times for more

Suggested Articles

Rachel Humphrey, M.D., who joined CytomX as chief medical officer after heading immuno-oncology at AstraZeneca and Eli Lilly, has made her exit.

Scientists have discovered a scorpion toxin could inspire treatments to block the inflammation that triggers chronic pain.

The phase 2 success keeps Hal Barron’s group on track to file for approval in multiple myeloma by the end of the year.